Universal Health Services Statistics
Total Valuation
UHS has a market cap or net worth of $10.69 billion. The enterprise value is $15.80 billion.
Market Cap | 10.69B |
Enterprise Value | 15.80B |
Important Dates
The last earnings date was Wednesday, April 24, 2024, after market close.
Earnings Date | Apr 24, 2024 |
Ex-Dividend Date | Jun 3, 2024 |
Share Statistics
UHS has 59.68 million shares outstanding. The number of shares has decreased by -4.20% in one year.
Shares Outstanding | 59.68M |
Shares Change (YoY) | -4.20% |
Shares Change (QoQ) | -0.10% |
Owned by Insiders (%) | 4.00% |
Owned by Institutions (%) | 95.30% |
Float | 57.45M |
Valuation Ratios
The trailing PE ratio is 15.39 and the forward PE ratio is 13.13. UHS's PEG ratio is 1.87.
PE Ratio | 15.39 |
Forward PE | 13.13 |
PS Ratio | 0.72 |
Forward PS | 0.67 |
PB Ratio | 1.69 |
P/FCF Ratio | 17.96 |
PEG Ratio | 1.87 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.62, with an EV/FCF ratio of 26.75.
EV / Earnings | 19.35 |
EV / Sales | 1.08 |
EV / EBITDA | 8.62 |
EV / EBIT | 12.49 |
EV / FCF | 26.75 |
Financial Position
The company has a current ratio of 1.38, with a Debt / Equity ratio of 0.85.
Current Ratio | 1.38 |
Quick Ratio | 1.16 |
Debt / Equity | 0.85 |
Debt / EBITDA | 2.90 |
Debt / FCF | 8.99 |
Interest Coverage | 6.06 |
Financial Efficiency
Return on equity (ROE) is 13.30% and return on invested capital (ROIC) is 8.59%.
Return on Equity (ROE) | 13.30% |
Return on Assets (ROA) | 5.90% |
Return on Capital (ROIC) | 8.59% |
Revenue Per Employee | $151,583 |
Profits Per Employee | $8,444 |
Employee Count | 96,700 |
Asset Turnover | 1.05 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, UHS has paid $239.66 million in taxes.
Income Tax | 239.66M |
Effective Tax Rate | 22.69% |
Stock Price Statistics
The stock price has increased by +32.22% in the last 52 weeks. The beta is 1.27, so UHS's price volatility has been higher than the market average.
Beta (1Y) | 1.27 |
52-Week Price Change | +32.22% |
50-Day Moving Average | 172.12 |
200-Day Moving Average | 149.15 |
Relative Strength Index (RSI) | 60.13 |
Average Volume (30 Days) | 693,680 |
Short Selling Information
The latest short interest is 2.24 million, so 3.76% of the outstanding shares have been sold short.
Short Interest | 2.24M |
Short Previous Month | 1.46M |
Short % of Shares Out | 3.76% |
Short % of Float | 3.91% |
Short Ratio (days to cover) | 3.00 |
Income Statement
In the last 12 months, UHS had revenue of $14.66 billion and earned $816.51 million in profits. Earnings per share was $11.78.
Revenue | 14.66B |
Gross Profit | 14.66B |
Operating Income | 1.29B |
Pretax Income | 1.06B |
Net Income | 816.51M |
EBITDA | 1.83B |
EBIT | 1.26B |
Earnings Per Share (EPS) | $11.78 |
Balance Sheet
The company has $112.09 million in cash and $5.31 billion in debt, giving a net cash position of -$5.20 billion or -$87.05 per share.
Cash & Cash Equivalents | 112.09M |
Total Debt | 5.31B |
Net Cash | -5.20B |
Net Cash Per Share | -$87.05 |
Equity / Book Value | 6.26B |
Book Value Per Share | 104.84 |
Working Capital | 795.59M |
Cash Flow
In the last 12 months, operating cash flow was $1.37 billion and capital expenditures -$782.84 million, giving a free cash flow of $590.61 million.
Operating Cash Flow | 1.37B |
Capital Expenditures | -782.84M |
Free Cash Flow | 590.61M |
FCF Per Share | $8.79 |
Margins
Gross margin is 100.00%, with operating and profit margins of 8.77% and 5.57%.
Gross Margin | 100.00% |
Operating Margin | 8.77% |
Pretax Margin | 7.21% |
Profit Margin | 5.57% |
EBITDA Margin | 12.50% |
EBIT Margin | 8.63% |
FCF Margin | 4.03% |
Dividends & Yields
This stock pays an annual dividend of $0.80, which amounts to a dividend yield of 0.45%.
Dividend Per Share | $0.80 |
Dividend Yield | 0.45% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | 6.79% |
Buyback Yield | 4.20% |
Shareholder Yield | 4.65% |
Earnings Yield | 7.70% |
FCF Yield | 5.57% |
Analyst Forecast
The average price target for UHS is $183.07, which is 2.09% higher than the current price. The consensus rating is "Buy".
Price Target | $183.07 |
Price Target Difference | 2.09% |
Analyst Consensus | Buy |
Analyst Count | 15 |
Revenue Growth Forecast (5Y) | 5.34% |
EPS Growth Forecast (5Y) | 16.16% |
Stock Splits
The last stock split was on December 16, 2009. It was a forward split with a ratio of 2:1.
Last Split Date | Dec 16, 2009 |
Split Type | Forward |
Split Ratio | 2:1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 7 |